Top Story

PALB2 mutations may increase risk for breast cancer mortality

<i>PALB2</i> mutations may increase risk for breast cancer mortality
June 29, 2015

Women harboring a PALB2 mutation face an increased risk for breast cancer and a potentially increased risk for breast cancer mortality compared with non-carriers, according to the results of a prospective cohort study.

Previous research has indicated PALB2 mutations predispose women for breast cancer. However, the effect of PALB2 mutations on disease prognosis remained unknown, according to study background.

In the Journals

Incidence of in situ, invasive melanoma increasing

June 29, 2015
Recent study results from Denmark showed an increase in melanoma incidence, and emphasized the importance of primary prevention in children and young adults and…
In the Journals

TE accurate in diagnosing subclinical cirrhosis in patients at risk for HBV-related HCC

June 29, 2015
Researchers in Korea used transient elastography and found it to be useful in identifying subclinical cirrhosis among patients at risk for hepatitis B virus…
In the Journals

Rates of insurance coverage increase due to same-sex marriage laws

June 29, 2015
Marriage equality laws were associated with increases in employer-sponsored health insurance and reductions in state-funded Medicaid assistance for both men and women in…
Bruce Haffty Breaking NewsPerspective

Oncology community reacts to ACA decision

June 29, 2015
The American Society for Radiation Oncology issued a favorable response to the U.S. Supreme Court ruling upholding health care subsidies under the Affordable Care Act in…
More News Headlines »
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
Meeting News Coverage Video
VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

June 19, 2015
CHICAGO — Vernon K. Sondak, MD, chair of the department of cutaneous oncology at Moffitt Cancer Center and a…
More »
CME
Hematology Oncology Case Consults

The Patient with Chronic Lymphocytic Leukemia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with chronic lymphocytic leukemia.
More »